Racial Differences Seen in Epigenetic Age Acceleration in Childhood Cancer Survivors
By Elana Gotkine HealthDay Reporter
TUESDAY, July 9, 2024 -- For childhood cancer survivors, there are racial and ethnic disparities in epigenetic age acceleration (EAA), which are partially mediated by social determinants of health (SDOH), according to a study published online July 2 in JAMA Network Open.
Cheng Chen, from The Fourth Affiliated Hospital of Soochow University in Suzhou, China, and colleagues compared non-Hispanic Black to non-Hispanic White survivors of childhood cancer by examining the associations of EAA with cancer treatment exposures and mediating roles of SDOH in a cross-sectional study. Data were included for 1,706 survivors, including 230 and 1,476 non-Hispanic Black and non-Hispanic White survivors, respectively.
The researchers found that EAA was significantly greater among non-Hispanic Black versus non-Hispanic White survivors (adjusted least-square means [ALSM], 1.41 and 0.47, respectively). Among non-Hispanic Black survivors, EAA was significantly increased among those exposed versus unexposed to chest radiotherapy (ALSM, 2.82 versus 0.46); among those exposed versus unexposed to alkylating agents (ALSM, 2.33 versus 0.95); and among those exposed versus unexposed to epipodophyllotoxins (ALSM, 2.83 versus 0.44). The association with epipodophyllotoxins differed by race and ethnicity (β, 2.39 and 0.68 years for non-Hispanic Black and non-Hispanic White survivors, respectively). Educational attainment and socioeconomic area deprivation index mediated racial and ethnic disparities in EAA (mediation, 22.71 and 22.16 percent, respectively).
"This finding suggests that changes in the social support system at both the personal and community levels may mitigate socioeconomic disadvantages that may contribute to the development of an aging phenotype," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-10 03:15
Read more
- How AI Might Help Men Fighting Prostate Cancer
- AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia
- AI Model FastGlioma Can Detect Glioma Infiltration During Surgery
- Metformin Use Tied to Lower Rate of Asthma Attacks
- FDA Approves Nerivio for Migraine Treatment in Children Aged 8 Years and Older
- ED Visit Rate 36.1 per 1,000 Older Adults With Alzheimer Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions